| Jennifer Tamburo Hotard, LPN | |
|
128 Woodland Dr, La Place, LA 70068-5939 | |
| (985) 651-3777 | |
| (985) 651-3770 |
| Full Name | Jennifer Tamburo Hotard |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 128 Woodland Dr, La Place, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023695228 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 20130252 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Tamburo Hotard, LPN 128 Woodland Dr, La Place, LA 70068-5939 Ph: (985) 651-3777 | Jennifer Tamburo Hotard, LPN 128 Woodland Dr, La Place, LA 70068-5939 Ph: (985) 651-3777 |
News Archive
Implant-based breast reconstruction, particularly immediate reconstruction, is associated with a higher failure rate than a free flap technique in obese people, suggest researchers.
The Hill Healthwatch: "Florida's 14-member insurance advisory board has unanimously passed a resolution to seek a waiver from the health law's medical loss ratio. An official with the Florida Office of Insurance Regulation tells The Hill that the board's vote means it's a 'done deal' that the state will formally seek some kind of waiver but the board is gathering public input through Oct. 8.
Funding cuts for malaria control are the single most common reason for the resurgence of the deadly disease, according to a new study that has linked overall weakened malaria control programs to the majority of global resurgences since 1930.
Medivir AB announced today that the Russian Ministry of Health has approved Sovriad (simeprevir) for the treatment of chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adults with compensated liver disease (including cirrhosis) who are treatment naïve or who have failed previous interferon therapy (pegylated or non-pegylated) with or without ribavirin. Russia will be the first country within EMEA to gain access to simeprevir, which represents a significant advance in hepatitis C treatment.
Neuralstem, Inc. today announced that its Phase I trial to treat Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) with its spinal cord stem cells has been approved by the Institutional Review Board (IRB) at Emory University in Atlanta, GA.
› Verified 2 days ago
Sheila Ann Phillips, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3044 English Colony Dr, La Place, LA 70068 Phone: 504-265-2645 | |
Mary Oconnor, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 193 Grove Park, La Place, LA 70068 Phone: 504-756-3517 Fax: 985-359-1530 | |
Lori Ellis, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 301 W Airline Hwy Ste 201, La Place, LA 70068 Phone: 504-517-2873 | |
Mrs. Cheryl Guilrnillo Cruse, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 501 Rue De Sante, La Place, LA 70068 Phone: 985-652-6700 Fax: 985-651-0540 | |
Mrs. Lana Lashall Johnson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 128 Woodland Dr, La Place, LA 70068 Phone: 985-651-3777 Fax: 985-651-3770 | |
Jovanna Diggs, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2225 Greenwood Dr, La Place, LA 70068 Phone: 504-957-0073 |